Earnings Reports — November 09, 2026 — Morning Update — Last 24 Hours (Pacific Time)

Executive Summary

The Q3 2026 earnings season delivered a broadly positive surprise rate, with beats outnumbering misses among companies that have already reported. Energy and financials stood out as clear bright spots — Constellation Energy, NRG, and KKR all posted substantial beats — while select tech and biotech names showed mixed results. The dominant cross-sector theme is AI's dual role: a demand driver for energy and semiconductors, and a cost headwind for software and platform companies.

Earnings Performance Breakdown

Only companies reporting actual results are classified below. Previews/outlooks are excluded.

🟢 Double Beats: ADC Therapeutics, RB Global, Ferguson Enterprises, Constellation Energy, Monday.com, Ionis Pharma, KKR & Co, NRG Energy, Delcath Systems, Immunovant, Barrick Mining, Roivant Sciences, CNH Industrial (beat EPS), Editas Medicine, Village Farms, Compugen, Marti Technologies, Abeona Therapeutics, Ajinomoto, Kokusai Electric, Fujifilm, ANZ Group

⚪ Mixed: CECO Environmental, Vivid Seats, Affiliated Managers, Orthofix, Kamada, Evgo, Heron Therapeutics, Quanterix, Turning Point Brands, Lincoln Educational, Select Water, TG Therapeutics, Virtus, CNH Industrial (revenue miss), Dole, National Energy Services, WhiteHorse Finance, Superior of Companies, Bowman Consulting, Mistras, RadNet, Mitsui OSK

🔴 Double Misses: Uniti Group, Immunitybio, Coincheck Group, Ocular Therapeutix, Sable Offshore, Motorcar Parts, PowerFleet, CEVA, Hain Celestial, Opal Fuels, Somnigroup International, Global Self Storage, Kubota, Tonix

Notable Earnings Reports

🟢 Constellation Energy (CEG) — Double Beat

• EPS of $5.06, beat by $1.34; revenue also topped estimates
• Shares up 4%+ in premarket trading
• Nuclear power demand tied to AI data centers is driving outsized results; company raised its outlook

🟢 KKR & Co (KKR) — Double Beat

• EPS of $1.78, beat by $0.19; revenue topped estimates
• Record quarterly profit; plans to return over $40 billion to investors
• Accelerated asset sales and strong fundraising drove the record result

🟢 NRG Energy (NRG) — Double Beat

• EPS of $4.68, beat by $1.52; revenue topped estimates
• One of the largest EPS surprise magnitudes in this cycle
• Power demand tailwinds, though Texas market headwinds were flagged ahead of the print

🟢 Monday.com (MNDY) — Double Beat, Stock Fell

• EPS of $2.14, beat by $0.77; revenue topped estimates
• Shares fell 7.3% despite the beat
• Near-term operational headwinds flagged by management overshadowed the strong print

🔴 Sable Offshore (SOC) — Double Miss + Collapse

• EPS of -$1.37, missed by $1.27; revenue also fell short
• Shares tumbled 75% after crude oil sales were halted in October
• The operational shutdown rendered the quarter's financials largely irrelevant to the market reaction

🟢 Ionis Pharma (IONS) — Double Beat

• EPS of $0.66, beat by $1.87 vs. estimate of -$1.21 — one of the largest magnitude beats in the batch
• Revenue also topped estimates
• A dramatic swing to profitability relative to expectations

🟢 Ferguson Enterprises (FERG) — Double Beat

• Results "significantly exceeded" analyst expectations; guidance raised
• Shares described as soaring on the print
• Margin resilience and raised guidance signal distributor demand remains firm

🟢 Immunovant (IMVT) — Double Beat

• Shares jumped 11.7% in early trading
• Positive drug trial results combined with an earnings beat drove the move
• Pipeline momentum is the primary catalyst

🔴 Monday.com / Somnigroup / Kingspan — Guidance Concerns

• Somnigroup cut its full-year earnings forecast, shares fell 8% premarket
• Kingspan shares fell 3% after core insulation sales missed and guidance was left unchanged
• Both highlight demand softness in consumer and construction end markets

🟢 UniCredit — Double Beat

• Shares gained 5%+ after beating Q3 profit estimates and raising 2026 guidance
• Italy's second-largest bank is benefiting from higher-for-longer rate environment in Europe

Sector Analysis

🟢 Energy (Nuclear & Power)
Constellation Energy and NRG both posted large beats with raised guidance. The AI data center buildout is creating sustained, structural electricity demand — nuclear assets in particular are being re-rated higher. This is the clearest sector-wide theme of the reporting period.

🟢 Financials & Asset Management
KKR posted record profit and plans a $40B+ investor return. Affiliated Managers beat EPS by $0.71. UniCredit surged 5%+ on a beat and raised guidance. Alternative asset managers are benefiting from elevated deal activity and fundraising momentum.

🟢 Biotech / Pharma
Immunovant (+11.7%), Ionis Pharma (massive EPS beat), Roivant Sciences, Editas Medicine, and ADC Therapeutics all beat. The sector is showing broad positive momentum, though Ocular Therapeutix, Immunitybio, and Heron Therapeutics missed.

⚪ Technology / Software
Monday.com beat handily but fell 7.3% on operational headwind commentary — a classic "sell the news" reaction amplified by forward guidance concerns. AI spending is compressing near-term margins for platform companies even as it drives top-line growth.

🔴 Industrials / Construction
Kingspan missed and left guidance unchanged; GEA Group's strong orders failed to lift guidance; Kubota missed; Dole missed EPS by $0.18. Cost pressures and demand softness are weighing on this group.

🔴 Crypto-Adjacent / Speculative
Coincheck Group missed on both EPS and revenue. Sharplink beat on paper but shares fell — the market is skeptical of crypto treasury pivots as a business model. Sable Offshore's 75% collapse is the most dramatic single-stock event.

🟢 Japan / International
Ajinomoto raised its full-year profit forecast. SoftBank Corp raised its full-year outlook after record H1 revenue. Fujifilm beat Q2 profit estimates. Mitsui OSK beat and announced a buyback. Japanese corporates are broadly outperforming, aided partly by yen dynamics.

Biggest Movers

Largest EPS Surprise Magnitudes:

• 🟢 Ionis Pharma: +$1.87 beat
• 🟢 NRG Energy: +$1.52 beat
• 🟢 Constellation Energy: +$1.34 beat
• 🔴 Sable Offshore: -$1.27 miss
• 🔴 Bowman Consulting: -$0.65 miss
• 🟢 Monday.com: +$0.77 beat
• 🟢 Affiliated Managers: +$0.71 beat

Earnings Sentiment

Net Sentiment: 🟢 Cautiously Bullish
Beats are outpacing misses at roughly a 2:1 ratio among reported results, and the largest surprises skew positive.

Guidance is a mixed picture: Constellation Energy, Ferguson, Ajinomoto, SoftBank Corp, and UniCredit all raised outlooks, while Somnigroup cut its forecast and Kingspan left guidance unchanged despite a miss. The energy and financials sectors are providing the strongest upward guidance revisions. Stock reactions, however, are not uniformly rewarding beats — Monday.com's 7.3% drop on a strong beat is a reminder that forward commentary matters as much as the headline number. The overall tone is constructive but selective.

Market Implications

Energy as the AI Proxy Trade: Constellation Energy and NRG's outsized beats — both with raised guidance — reinforce the thesis that power infrastructure is the most direct beneficiary of AI data center buildout. Nuclear in particular is being repriced as a structural growth asset, not just a utility. Investors rotating into energy as an AI play may find continued validation in upcoming prints.

Financials Firing on Multiple Cylinders: KKR's record profit and $40B+ return commitment, combined with UniCredit's raised guidance and strong alternative asset manager results, suggest the financial sector is in a strong position. Rising deal activity, elevated rates in Europe, and robust fundraising are all contributing. This is a broadly positive signal for risk appetite.

Software/Tech Faces a "Beat and Retreat" Dynamic: Monday.com's 7.3% drop despite a $0.77 EPS beat is emblematic of a market that is scrutinizing forward guidance more than backward results. AI investment cycles are compressing near-term margins for platform companies, and investors appear unwilling to pay for beats that come with cautious outlooks. This dynamic is likely to persist through the remainder of earnings season for software names.

Key Takeaways

• 🟢 Constellation Energy (CEG) — $1.34 EPS beat and raised guidance confirm nuclear power is the clearest structural winner from AI data center demand.
• 🟢 KKR (KKR) — Record quarterly profit and a $40B+ investor return signal alternative asset managers are in a strong cycle; watch fundraising metrics closely.
• 🟢 NRG Energy (NRG) — $1.52 EPS beat is one of the largest in this batch; power demand tailwinds are real and broad-based.
• 🔴 Sable Offshore (SOC) — A 75% single-day collapse after crude oil sales were halted in October is a stark reminder that operational disruptions can dwarf any earnings beat/miss.
• 🔴 Monday.com (MNDY) — Beat by $0.77 but fell 7.3%; in this market, forward guidance and operational commentary matter more than the headline number.
• 🔴 Somnigroup (SGI) — Cut full-year forecast and fell 8% premarket; consumer discretionary/bedding demand is softening.
• 🟢 Ionis Pharma (IONS) — A $1.87 EPS beat (swinging from expected loss to profit) is one of the most dramatic positive surprises in the batch.
• 🟢 Ferguson Enterprises (FERG) — Significant beat plus raised guidance suggests industrial distribution demand is holding up better than feared.
• 🟢 Immunovant (IMVT) — +11.7% on trial results plus earnings beat; clinical pipeline catalysts are driving outsized moves in biotech.
• 🟢 UniCredit — +5% on raised 2026 guidance; European banks continue to benefit from the higher-rate environment.
• 🟡 Japan Inc. broadly outperforming — Ajinomoto, SoftBank Corp, Fujifilm, and Mitsui OSK all beat or raised guidance; yen dynamics and materials demand are key tailwinds.
• 🔴 Industrials under pressure — Kubota, GEA, Kingspan, and Dole all missed or disappointed; cost pressures and demand softness are a recurring theme.
• 🟡 Crypto-adjacent names remain volatile — Sharplink fell despite a beat; Coincheck missed; the market is skeptical of crypto treasury strategies as fundamental business drivers.
• 🟡 Take-Two Interactive (TTWO) — Reports tonight just 10 days before GTA 6 launch; the print is almost secondary to what management says about the launch trajectory.
• 🟡 GoodRx (GDRX) — Faces an accounting restatement overhang heading into its Q3 print; clarity on that issue will matter more than the headline EPS number.

Independent, data-driven signals.
No hype. No promotions. Just experimental market research from EverHint.

This is not financial advice. Insider transactions can have many motivations beyond stock outlook.
Do your own due diligence.
See https://www.everhint.com/disclaimer/ and https://www.everhint.com/faqs/